Guideline Updates in the Management of People with Type 2 Diabetes and Implications to Patient Care
Originally presented on June 9, 2021 by Ted Okerson, MD, FACP, FACE, FTOS; Paul Tomasic, MD, MS, FACP, FACE; Davida F. Kruger, MSN, APN-BC, BC-ADM; and Curtis Triplitt, PharmD, CDCES
Hear from a variety of expert panelists on the most recent guideline updates and practical guidance for patient care. Understand some of the nuances of guideline recommendations based on data from recent clinical trials and outcomes studies.
Upon completion of this activity, participants will be able to:
- Become familiar with evidence from recent landmark CVOTs (cardiovascular outcome trials) and updated guidelines to help appropriately individualize the management of people with type 2 diabetes.
- Understand new treatment pathways based on CV risk assessment of people with type 2 diabetes
- Recognize the need to manage CV risk factors within the paradigm of the overall management of type 2 diabetes and associated macrovascular complications.